Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

AcelRx Pharmaceuticals Appoints Vice-President Of Commercial Strategy

This article was originally published in Scrip

Executive Summary

AcelRx Pharmaceuticals, a company focused on acute pain, has appointed Gina Ford vice-president of commercial strategy. She has worked with the company since 2013 as consultant and was involved in the development of a commercial strategy for Zalviso (sufentanil), which is now approved in Europe. Prior to joining AcelRx, Ford ran her own consulting firm. She was also president of Accesia (a wholly owned subsidiary of Patient Services, Inc.) and has also held various leadership positions at Ipsen.



Related Companies